Cresset Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Cresset Asset Management's ABBV Position: Q2 2026 in Review
Cresset Asset Management increased its AbbVie (ABBV) stake by 5.1% in Q2 2026, buying an estimated $1.99M and bringing the position to 190,827 shares worth $48M. The position accounts for 0.17% of the portfolio, ranked #92.
Cresset Asset Management first reported a position in ABBV in Q4 2018 and has held it in 31 quarters since. The position peaked at $67.7M in Q3 2024. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Cresset Asset Management held 190,827 shares of AbbVie worth $48M as of Q2 2026.
- Cresset Asset Management bought 9,241 AbbVie shares in Q2 2026, an estimated $1.99M.
- AbbVie made up 0.17% of Cresset Asset Management's portfolio in Q2 2026, its #92 holding.
- Cresset Asset Management first reported a position in AbbVie in Q4 2018 and has held it in 31 quarters since.
- Cresset Asset Management's AbbVie position peaked at $67.7M in Q3 2024.
- 4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Cresset Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.